US 11,701,654 B2
Fluid connector
Vladimir Azersky, San Jose, CA (US); Fabian Gerlinghaus, South San Francisco, CA (US); Daniele Malleo, Menlo Park, CA (US); Brian Alexander Pesch, San Francisco, CA (US); Bharat S. Thakkar, Campbell, CA (US); and Wilson Wai Toy, San Francisco, CA (US)
Assigned to Cellares Corporation, South San Francisco, CA (US)
Filed by Cellares Corporation, South San Francisco, CA (US)
Filed on Nov. 22, 2022, as Appl. No. 17/992,784.
Application 17/849,422 is a division of application No. 17/331,556, filed on May 26, 2021, granted, now 11,376,587, issued on Jul. 5, 2022.
Application 17/992,784 is a continuation of application No. 17/849,422, filed on Jun. 24, 2022.
Application 17/331,556 is a continuation of application No. 17/198,134, filed on Mar. 10, 2021.
Claims priority of provisional application 62/987,745, filed on Mar. 10, 2020.
Claims priority of provisional application 63/093,038, filed on Oct. 16, 2020.
Prior Publication US 2023/0149922 A1, May 18, 2023
Int. Cl. B01L 3/00 (2006.01); A61L 2/04 (2006.01); A61L 2/20 (2006.01); A61L 2/08 (2006.01); B01J 19/00 (2006.01); C12M 3/00 (2006.01); C12M 1/00 (2006.01); C12M 1/36 (2006.01); C12N 5/00 (2006.01)
CPC B01L 3/502715 (2013.01) [A61L 2/04 (2013.01); A61L 2/20 (2013.01); A61L 2/206 (2013.01); A61L 2/208 (2013.01); B01J 19/004 (2013.01); B01L 13/00 (2019.08); C12M 23/44 (2013.01); C12M 23/50 (2013.01); C12M 41/48 (2013.01); C12N 5/00 (2013.01); C12N 5/0081 (2013.01); A61L 2/08 (2013.01); A61L 2202/11 (2013.01); A61L 2202/122 (2013.01); A61L 2202/123 (2013.01); A61L 2202/14 (2013.01); B01J 2219/0002 (2013.01); B01J 2219/0074 (2013.01); B01L 2200/027 (2013.01); B01L 2300/049 (2013.01)] 29 Claims
OG exemplary drawing
 
1. A system for processing cell products in parallel comprising:
a sterile enclosure;
at least one robotic arm positioned within the sterile enclosure, the at least one robotic arm attached to a linear rail;
a first cartridge including a port and a liquid transfer bus, wherein the first cartridge is capable of receiving a cell product to be processed and of interfacing with one or more instruments;
a first instrument including a first slot positioned within the sterile enclosure, the first instrument comprising a sterile liquid transfer instrument configured to transfer fluid in and out of the first cartridge via the port; and
a second instrument including a second slot positioned within the sterile enclosure, the second instrument comprising a bioreactor instrument configured to enable expansion of cells within the first cartridge,
wherein the at least one robotic arm is configured to move the first cartridge between the first slot within the first instrument and the second slot within the second instrument in order to process a cell product within the first cartridge.